In this captivating episode, host David Brühlmann welcomes James Ryall, a strategic consultant with over two decades of experience in cell biology and regenerative medicine. From his groundbreaking work in skeletal muscle research to revolutionizing cultured meat production, James shares his fascinating journey through academia and industry.
Discover how he's now helping biotech startups align their technical strategies with commercial outcomes, accelerating their path to market.
You will gain invaluable insights on:
- Navigating the transition from academia to industry
- Scaling cell production from lab quantities to industrial volumes
- Identifying and pivoting to the right target market for biotech innovations
Don't miss this eye-opening discussion on simplifying bioprocessing and bringing game-changing products to life. Tune in now to supercharge your biotech career!
Connect with James Ryall:
LinkedIn: https://www.linkedin.com/in/james-ryall
Website: https://www.jamesryall.com
Next Steps:
Wondering how to develop biologics with clarity and precision? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Contact us at https://bruehlmann-consulting.com
One bad CDMO decision can cost you two years and your Series A. If you're navigating tech transfer, CDMO selection, or IND prep, let's talk before it gets expensive. Two slots open this month.
Support the show
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders